4/26
08:01 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) is now covered by analysts at B. Riley. They set a "buy" rating and a $25.00 price target on the stock.
Low
Report
MacroGenics, Inc. (NASDAQ: MGNX) is now covered by analysts at B. Riley. They set a "buy" rating and a $25.00 price target on the stock.
4/24
03:08 am
mgnx
Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair [Yahoo! Finance]
Low
Report
Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair [Yahoo! Finance]
4/19
07:32 am
mgnx
We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely [Yahoo! Finance]
Low
Report
We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely [Yahoo! Finance]
4/9
08:09 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating.
Medium
Report
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating.
4/5
03:11 am
mgnx
MacroGenics: Positive Safety Update Leads To Two Major Inflection Points In 2024 [Seeking Alpha]
Medium
Report
MacroGenics: Positive Safety Update Leads To Two Major Inflection Points In 2024 [Seeking Alpha]
4/4
10:07 am
mgnx
ARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare movers [Seeking Alpha]
Neutral
Report
ARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare movers [Seeking Alpha]
4/4
09:06 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) had its "market outperform" rating re-affirmed by analysts at JMP Securities.
High
Report
MacroGenics, Inc. (NASDAQ: MGNX) had its "market outperform" rating re-affirmed by analysts at JMP Securities.
4/4
07:01 am
mgnx
MacroGenics gains after mid-stage data for antibody drug conjugate [Seeking Alpha]
High
Report
MacroGenics gains after mid-stage data for antibody drug conjugate [Seeking Alpha]
11/6/2023
04:01 pm
mgnx
macrogenics, inc.
BEAT
Report
17.1%
macrogenics, inc.
8/9/2023
04:01 pm
mgnx
macrogenics, inc.
BEAT
Report
24.3%
macrogenics, inc.
5/9/2023
04:01 pm
mgnx
macrogenics, inc.
MISS
Report
0.4%
macrogenics, inc.
4/8
06:07 pm
mgnx
Form 4 MACROGENICS INC For: Apr 04 Filed by: Peters Jeffrey Stuart
Low
Report
Form 4 MACROGENICS INC For: Apr 04 Filed by: Peters Jeffrey Stuart
4/8
04:34 pm
mgnx
Form ARS MACROGENICS INC For: Dec 31
Low
Report
Form ARS MACROGENICS INC For: Dec 31
4/8
04:33 pm
mgnx
Form DEFA14A MACROGENICS INC
Low
Report
Form DEFA14A MACROGENICS INC
4/8
04:32 pm
mgnx
Form DEF 14A MACROGENICS INC For: May 21
Low
Report
Form DEF 14A MACROGENICS INC For: May 21
4/4
04:58 pm
mgnx
Form 144 MACROGENICS INC Filed by: Peters Jeffrey Stuart
Low
Report
Form 144 MACROGENICS INC Filed by: Peters Jeffrey Stuart
4/3
05:25 pm
mgnx
Form 8-K MACROGENICS INC For: Apr 03
High
Report
Form 8-K MACROGENICS INC For: Apr 03
3/8
04:15 pm
mgnx
Form 4 MACROGENICS INC For: Mar 06 Filed by: Peters Jeffrey Stuart
Medium
Report
Form 4 MACROGENICS INC For: Mar 06 Filed by: Peters Jeffrey Stuart
3/7
04:07 pm
mgnx
Form 10-K MACROGENICS INC For: Dec 31
High
Report
Form 10-K MACROGENICS INC For: Dec 31
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register